Diagnosing restless legs syndrome (RLS) in primary care

Current Medical Research and Opinion

Volumn 20, Issue 11, 2004, Pages 1785-1795

  Chaudhuri, K Ray ^a   Forbes, Alison ^a   Grosset, Donald ^b   Lees, Andrew ^c   Shneerson, John ^d   Schapira, Anthony ^c,e   Stillman, Paul ^f   Williams, Adrian ^g  

^a UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

^b SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d PAPWORTH HOSPITAL   (United Kingdom)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^f St Thomas' Hospital ^*

^g ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Diagnosis; Primary care; Quality of life; Restless legs syndrome (RLS); Sleep disturbance

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; QUININE;

ADULT; DEPRESSION; DISEASE SEVERITY; GENERAL PRACTICE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; REVIEW; SLEEP DISORDER; SYMPTOMATOLOGY;

HUMANS; PRIMARY HEALTH CARE; RESTLESS LEGS SYNDROME;

EID: 10044255234     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079904X5472     Document Type: Review

References (58)

1. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-19
2. Walters AS, Hening WA, Kavey N, et al. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 1988;24:455-8
3. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 1999;52:938-43
4. Akpinar S. Treatment of restless legs syndrome with levodopa plus benserazide. Arch Neurol 1982;39:739
5. Wellbery CE. Getting the facts on restless Legs. Am Fam Physician 2000;62:51-2
6. Allen RP, Earley CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 2001;18:128-47
7. Allen R, Walters A, Hening W, et al. Factors affecting the quality of life of adults with RLS a population-based survey. Eur J Neurol 2003;10(Suppl. 1):138-9
8. Walters AS, Allen RP, Hening W, et al. The impact of restless legs syndrome symptoms on quality of life: a population-based survey in the USA. Sleep 2003;26(Abstract Suppl):A329 [0827.N]
9. Kirsch J, Abetz L, Allen R, et al. The impact of restless legs syndrome (RLS) on quality of life (QoL). Eur J Neurol 2002;9(Suppl 2):198 [P3136]
10. Ekbom K-A. Restless Legs. Acta Med Scand 1945;158(Suppl): 1-123
11. Phillips B, Young T, Finn L, et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137-41
12. Chokroverty S, Jankovic J. Restless legs syndrome: a disease in search of identity. Neurology 1999;52:907-10
13. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994;17:739-43
14. Rothdach AJ, Trenkwalder C, Haberstock J, et al. Prevalence and risk factors of RLS in an elderly population: the MEMO Study. Neurology 2000;54:1064-8
15. Kageyama T, Kabuto M, Nitta H, et al. Prevalences of periodic limb movement-like and restless legs-like symptoms among Japanese adults. Psychiatry Clin Neurosci 2000;54:296-8
16. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002;53:547-54
17. Hening W, Walters AS, Allen RP, et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS Epidemiology, Symptoms, and Treatment) Primary Care study. Sleep Med 2004;5:237-46
18. Hening W, Allen R, Walters AS, et al. Prevalence of restless legs syndrome (RLS) and impact of symptoms on the quality of life of sufferers. Eur J Neurol 2003;10(Suppl 1):43 [SC 338]
19. Montplaisir J, Walters AS, Allen RP, Hening W. Impact of restless legs syndrome (RLS) symptoms on the health and quality of life of sufferers. Sleep 2003;26(Abstract Suppl):A333 [0836.N]
20. Walters AS, Picchietti DL, Ehrenberg BL, Wagner ML. Restless legs syndrome in childhood and adolescence. Pediatr Neurol 1994;11:241-5
21. Roehrs T, Zorick F, Sicklesteel J, et al. Age-related sleep-wake disorders at a sleep disorder center. J Am Geriatr Soc 1983;31:364-70
22. Hening W, Allen R, Earley C, et al. The treatment of restless legs syndrome and periodic limb movement disorder. Sleep 1999;22:970-99
23. Walters AS, Hickey K, Maltzman J, et al. A questionnaire study of 138 patients with restless legs syndrome: the 'Night-Walkers' survey. Neurology 1996;46:92-5
24. Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004;164:196-202
25. Silber MH. Restless legs syndrome. Mayo Clin Proc 1997;72:261-4
26. Evidente VGH, Adler CH. How to help patients with restless legs syndrome: discerning the indescribable and relaxing the restless. Postgrad Med 1999;105:59-74
27. O'Keeffe ST. Restless legs syndrome: a review. Arch Intern Med 1996;156:243-8
28. Amar K. Overview of restless legs syndrome. Hosp Med 2001;62:487-9
29. Winkelmann J, Muller-Myhsok B, Wittchen H-U, et al. Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol 2002;52:297-302
30. Sowers JR, Vlachakis N. Circadian variation in plasma dopamine levels in man. J Endocrinol Invest 1984;7:341-5
31. 11C-raclopride PET studies. Neurology 1999;52:932-7
32. Ruottinen HM, Partinen M, Hublin C, et al. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology 2000;54:502-4
33. Michaud M, Soucy JP, Chabli A, et al. SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol 2002;249:164-170
34. Trenkwalder C, Walters AS, Hening WA, et al. Positron emission tomographic studies in restless legs syndrome. Mov Disord 1999;14:141-5
35. Chaudhuri KR. The restless legs syndrome: time to recognize a very common movement disorder. Prac Neurol 2003;3:204-13
36. Stiasny-Kolster K, Mageri W, Oertel WH, et al. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain 2004;127:773-82
37. Walters AS. Review of receptor agonist and antagonist studies relevant to the opiate system in restless legs syndrome. Sleep Med 2002;3:301-4
38. Montplaisir J, Lorrain D, Godbout R. Restless legs syndrome and periodic leg movements in sleep: the primary role of dopaminergic mechanism. Eur Neurol 1991;31:41-3
39. Earley CJ, Connor JR, Beard JL, et al. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000;54:1698-700
40. Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003;61:304-9
41. Winkelmann J, Stautner A, Samtleben W, Trenkwalder C. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation. Mov Disord 2002;17:1072-6
42. Restless Legs Foundation. Medical bulletin. Rochester (MN): RLS Foundation; Revised April 2004. http://www.rls.org Accessed 6 July 2004
43. Davis BJ, Rajput A, Rajput ML, et al. A randomised, double-blind, placebo-controlled trial of iron in restless legs syndrome. Eur Neurol 2000;43:70-5
44. Walsh JK. Chronic insomnia, ability to function and quality of life. International Workshop, Worldwide Project on Sleep and Health 1997. http://www.websciences.org/sleepandhealth/walsh.html Accessed 29 March 2004
45. Lichstein KL, Durrence HH, Taylor DJ, et al. Quantitative criteria for insomnia. Behav Res Ther 2003;41:427-45
46. Neubauer DN. Sleep problems in the elderly. Am Fam Physician 1999;59:2551-8, 2559-60
47. Trenkwalder C, Hundemer H-P, Lledo A, et al. Efficacy of pergolide in treatment of restless legs syndrome. The PEARLS study. Neurology 2004;62:1391-7.
48. Earley CJ. Restless legs syndrome. New Engl J Med 2003;348:2103-9
49. Chokroverty S. Disorders of sleep. Sci Am Med 2000;11(xiii):1-8
50. Petri H, van de Vijver D, Sampson T. Assessing characteristics of patients diagnosed with restless legs syndrome using a primary care database. Poster presented at 7th International Congress of Parkinson's Disease and Movement Disorders, November 2002
51. Allen R, Hening W, Montplaisir J, et al. Diagnosis, treatment and referral of patients with symptoms of restless legs syndrome (RLS): the RLS Epidemiology, Symptoms and Treatment (REST) primary care study. Eur J Neurol 2003;10(Suppl 1):43 [SC 339]
52. Walters AS. Toward a better definition of the restless legs syndrome. Mov Disord 1995;10:634-42
53. Odin P, Mrowka M, Shing M. Restless legs syndrome. Eur J Neurol 2002;9(Suppl 3):59-67
54. Montplaisir J, Boucher S, Nicolas A, et al. Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome. Mov Disord 1998;13:324-9
55. Lutz EG. Restless legs, anxiety and caffeinism. J Clin Psychiatry 1978;39:693-8
56. Managing patients with restless legs. Drug and Therapeutics Bulletin 2003;41:81-3
57. Hening WA, Allen RP, Earley CJ, et al. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 2004;27:560-83 Allen RP, Becker P, Bogan R, et al. Restless legs syndrome: the efficacy of ropinirole in the treatment of RLS patients suffering from periodic leg movements of sleep. Sleep 2003;26(Abstract Suppl):A341 [0858.N]
58. Hening WA, Allen RP, Earley CJ, et al. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 2004;27:560-83 Allen RP, Becker P, Bogan R, et al. Restless legs syndrome: the efficacy of ropinirole in the treatment of RLS patients suffering from periodic leg movements of sleep. Sleep 2003;26(Abstract Suppl):A341 [0858.N]